Viewing nowElsartan Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Poonglim Pharmaceutical Co., Ltd.

MFDS item code 201505005 · Approved 2015.07.23
Treatment of hypertension and kidney disease in patients with type 2 diabetes mellitus and hypertension
This medication is used to treat hypertension and helps improve symptoms of kidney disease that may occur in patients with type 2 diabetes. It reduces risks associated with hypertension and protects kidney function, thus enhancing the overall health of the patient. It stabilizes blood pressure and is effective in preventing complications.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and taken orally twice daily, or increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider a lower dose in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication should not be taken by pregnant women, especially during the second and third trimesters, as it can cause serious harm to the fetus and newborn. It should not be administered to patients with allergies to this medication, severely impaired liver function, history of angioedema, primary hyperaldosteronism, and those with certain genetic lactose metabolism disorders. Elderly patients, those with slightly compromised kidney function, patients with hyperkalemia or those prone to elevated serum potassium levels, and patients with heart valve disease or cardiac hypertrophy should use this medication with caution, ensuring that blood pressure does not drop too low. While taking this medication, side effects such as muscle cramps, dizziness, cough, and upper respiratory tract infections may occur. Rarely, serious adverse reactions such as angioedema, liver dysfunction, renal failure, cardiac arrhythmias, and hypoglycemia may present, requiring immediate consultation with a healthcare professional if symptoms arise. Patients with compromised liver or kidney function may experience elevated blood concentrations or worsening kidney function while taking this medication, necessitating dose adjustments or regular monitoring. Severe renal failure patients must be particularly careful. When taken in conjunction with potassium-sparing diuretics, potassium supplements, or potassium-containing salt substitutes, this medication may cause dangerously elevated blood potassium levels; hence, these combinations should be avoided. Caution should be exercised when used with non-steroidal anti-inflammatory drugs (NSAIDs), as it may diminish the hypotensive effect and increase the risk of renal impairment. When combined with lithium, there is a risk of lithium toxicity; regular monitoring of serum levels is essential. Use of this medication during pregnancy increases the risks of reduced fetal kidney function, decreased amniotic fluid, skeletal deformities, and hypotension; therefore, it should be discontinued immediately upon confirmation of pregnancy. Lactating women should also avoid taking this medication. Regular monitoring of blood pressure, kidney function, and electrolyte levels is essential during treatment, and if dizziness or hypotension occurs, driving or operating machinery should be avoided. Overdose may result in severe hypotension or arrhythmias, necessitating immediate medical attention, as this medication is not removed by hemodialysis. Keep out of reach of children, and do not transfer the medication to another container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that prevents air entry, preferably between 1 to 30 degrees Celsius, to maintain its effectiveness over time.
White oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Poonglim Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.